Sign in / Join Now
ETFs & Funds
recent chart action. Price appreciation+Volume uptrend+
crossing = -50% share value! Didnot see it coming. Why? jdm
Drug fails trump technical analysis every time.
Technical analysis is in the eye of the beholder. How could such a promising chart be so empty of predictive value?...jdm
The old saying is
works until it doesn't.
Add a reply...
Latest StockTalks »
people get GERN breaking news and analysis by email alert.
Get email alerts on GERN »
Get latest price
From other sites
Geron Reports Imetelstat Presentations At American Society Of Hematology Annual Meeting
at TheStreet (Tue, 4:01PM)
Geron Announces November Investor Conference Presentation Webcasts
at TheStreet (Nov 7, 2016)
Geron (GERN) Reports Narrower-than-Expected Loss in Q3
at Zacks.com (Nov 4, 2016)
Geron Announces Presentations At American Society Of Hematology Annual Meeting
at TheStreet (Nov 3, 2016)
Geron (GERN) Q3 Earnings: Will the Store Pull a Surprise?
at Zacks.com (Nov 1, 2016)